About Speaker
David S. Karow, M.D., Ph.D., Chief of Radiogenomics and interim CEO at HLI, is an innovative leader who brings more than 10 years of experience in advanced MR Imaging and genomic analytics. Dr. Karow’s primary interest is to develop machine-learning based integrated diagnostics that leverage imaging, genetic, and clinical biomarkers to generate more insightful health assessments and identify disease in early stages when it is most treatable.
